AmpliPHY of Kentucky ACO LLC
4550 Montgomery Ave, Ste 950N
Bethesda, MD 20814
ACO Participants | ACO Participant in Joint Venture |
Advanced Internal Medicine PLLC | N |
Dr. Butler & Associates, PLLC | N |
FAMILY PRACTICE ASSOCIATES OF MAYSVILLE, P.S.C. | N |
Four Rivers Internal Medicine PLLC | N |
GOLDENBERG & ASSOCIATES | N |
INTEGRATED MEDICAL GROUP P C | N |
INTERMED PA | N |
James Kyle Turnbo MD PSC | N |
JAMES N EICKHOLZ MD PSC | N |
Jeffrey L. Riney M.D. & Associates PLLC | N |
JEREMY BRADLEY | N |
Kyle D. Parish, MD, PSC | N |
LACKAWANNA MEDICAL GROUP PC | N |
POTTSTOWN MEDICAL SPECIALISTS INC | N |
Total Life Care, PLLC | N |
Member First Name | Member Last Name | Member Title/Position | Member's Voting Power (Expressed as a percentage) | Membership Type | ACO Participant Legal Business Name |
JEREMY | BRADLEY | Board Member | 5.882 | ACO Participant Representative | Jeremy Bradley |
WADE | BROSIUS | Board Member | 5.882 | ACO Participant Representative |
Pottstown Medical Specialists Inc |
DANNY | BUTLER | Board Member/Compliance Committee Member | 5.882 | ACO Participant Representative |
Dr. Butler & Associates, PLLC |
LEIF | CHRISTIANSEN | Board Member | 5.882 | ACO Participant Representative |
Integrated Medical Group P C |
JAMES | EICKHOLZ | Board Member | 5.882 | ACO Participant Representative |
James N Eickholz MD PSC |
RYAN | FRAZINE | Board Member/ACO Medical Director | 5.882 | ACO Participant Representative |
Advanced Internal Medicine PLLC |
GEORGE | GALLENSTEIN | Board Member | 5.882 | ACO Participant Representative |
Family Practice Associates Of Maysville, P.S.C. |
CHARLES | GRAD | Board Member | 5.882 | ACO Participant Representative |
Lackawanna Medical Group PC |
PHYLLIDIA | KU-RUTH | Board Member | 5.882 | ACO Participant Representative | Intermed PA |
JASON | LORCH | Board Member | 5.882 | ACO Participant Representative |
Four Rivers Internal Medicine PLLC |
JEFF | MANDEL | Board Member/Chair | 5.882 | Other | Aledade |
JENNIFER | NELSON | Board Member | 5.882 | ACO Participant Representative |
Total Life Care, PLLC |
KYLE | PARISH | Board Member | 5.882 | ACO Participant Representative |
Kyle D. Parish, MD, PSC |
JEFFREY | RINEY | Board Member | 5.882 | ACO Participant Representative |
Jeffrey L. Riney M.D. & Associates PLLC |
SHABBIR | SHAIKH | Board Member | 5.882 | ACO Participant Representative |
Goldenberg & Associates |
PAT | STORM | Board Member/Medicare Beneficiary Representative | 5.882 | Medicare Beneficiary Representative | N/A |
JAMES | TURNBO | Board Member | 5.882 | ACO Participant Representative |
James Kyle Turnbo MD PSC |
Due to rounding, ‘Member’s Voting Power’ may not equal 100 percent.
- Executive Director: Jeff Mandel
- Medical Director: Ryan Frazine
- Compliance Officer: Amy Youtz
- Quality Assurance/Improvement Officer: Emily Maxson
Committee Name | Committee Leader Name and Position |
Compliance Committee | Danny Butler, MD / Compliance Committee Leader |
- Networks of individual practices of ACO professionals
-
Second Agreement Period
-
Performance Year 2022, $4,223,479.50
-
Performance Year 2021, $4,091,797
-
Performance Year 2020, $5,023,158
-
Performance Year 2019, $1,665,855
-
-
First Agreement Period
-
-
Performance Year 2019, $1,665,855
-
Performance Year 2018, $0
-
Performance Year 2017, $0
-
Performance Year 2016, $1,110,552
-
Note: Our ACO participated in multiple performance years during Calendar Year 2019. The shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Second Agreement Period
- Performance Year 2022
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 40%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2021
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 40%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2020
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 40%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2019
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 40%
- Proportion of distribution to ACO participants: 50%
First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 30%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2016
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 30%
- Proportion of distribution to ACO participants: 60%
Note: Our ACO participated in multiple performance years during Calendar Year 2019. The shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Measure # | Measure Name | Collection Type | Rate | ACO Mean |
Quality ID# 001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control [1] | CMS Web Interface | 8.97 | 10.71 |
Quality ID# 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 90.76 | 76.97 |
Quality ID# 236 | Controlling High Blood Pressure | CMS Web Interface | 88.33 | 76.16 |
Quality ID# 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 94.41 | 87.83 |
Quality ID# 110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 94.78 | 77.34 |
Quality ID# 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 100 | 79.27 |
Quality ID# 113 | Colorectal Cancer Screening | CMS Web Interface | 91.19 | 75.32 |
Quality ID# 112 | Breast Cancer Screening | CMS Web Interface | 90.13 | 78.07 |
Quality ID# 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 90.58 | 86.37 |
Quality ID# 370 | Depression Remission at Twelve Months | CMS Web Interface | 20 | 16.03 |
Quality ID# 321 | CAHPS for MIPS [3] | CMS Web Interface | N/A | N/A |
Measure# 479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups [1] | CMS Web Interface | 0.1373 | 0.151 |
Measure# 484 | Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions [1] | CMS Web Interface | 27.57 | 30.97 |
CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS | 91.84 | 83.96 |
CAHPS-2 | How Well Providers Communicate | CAHPS for MIPS | 95.83 | 93.47 |
CAHPS-3 | Patient’s Rating of Provider | CAHPS for MIPS | 94.39 | 92.06 |
CAHPS-4 | Access to Specialists | CAHPS for MIPS | 79.07 | 77 |
CAHPS-5 | Health Promotion and Education | CAHPS for MIPS | 65.58 | 62.68 |
CAHPS-6 | Shared Decision Making | CAHPS for MIPS | 69.31 | 60.97 |
CAHPS-7 | Health Status and Functional Status | CAHPS for MIPS | 72.26 | 73.06 |
CAHPS-8 | Care Coordination | CAHPS for MIPS | 89.03 | 85.46 |
CAHPS-9 | Courteous and Helpful Office Staff | CAHPS for MIPS | 94.25 | 91.97 |
CAHPS-11 | Stewardship of Patient Resources | CAHPS for MIPS | 32.39 | 25.62 |
ACO Pre-Participation Waiver:: N/A
ACO Participation Waiver: N/A